clinical trial · NCT06956014
Efficacy and Safety of VER-01 in the Treatment of Patients With Radicular Chronic Low Back Pain
Radicular Low Back PainVER-01Placebo
brief summary
The aim of the trial is to prove the efficacy and safety of VER-01 corresponding to 22.5 mg or 32.5 mg THC compared to placebo in patients with chronic low back pain (CLBP) with a radicular component for whom drug treatment is indicated and previous optimized treatments with non-opioid analgesics have not led to sufficient pain relief or were unsuitable due to contraindications or intolerance.
started
Sep 1, 2026
primary completion
Nov 1, 2027
completion
Nov 1, 2027
last updated
Mar 13, 2026
official title
Multicenter, Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of the Full-spectrum Cannabis Extract VER-01 in Patients With Radicular Chronic Low Back Pain
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol